Related Articles
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
Modern markers for evaluating bone disease in multiple myeloma (Review)
Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance
The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats
Knockdown of macrophage inhibitory cytokine-1 in RPMI-8226 human multiple myeloma cells inhibits osteoclastic differentiation through inhibiting the RANKL-Erk1/2 signaling pathway